James Healy
Sits on 6 boards. Overboarded · 6 public boards Last updated September 28, 2026
Time on boards
- Boards served
- 6
- Current seats
- 6
- Board service
- 15 years
- Director since
- 2023
15 years of board service in total across 6 boards, counting each seat separately. Longest: Natera Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
ArriVent BioPharma Inc. June 18, 202661.0%
-
BioAge Labs Inc. June 10, 202681.6%
-
Rapport Therapeutics Inc. June 10, 202698.6%
-
Bolt Biotherapeutics Inc. June 12, 202378.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +952,380 | $21.00 | $19,999,980 |
| Oct 28, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +6,395 | $21.00 | $134,295 |
| Oct 28, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +3,772 | $21.00 | $79,212 |
| Oct 28, 2026 | Rapport Therapeutics Inc. | Open-market purchase | +6,933 | $21.00 | $145,593 |
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +1,927,159 | — | — |
| May 4, 2026 | Seaport Therapeutics Inc. | Derivative conversion | +804,379 | — | — |
| Apr 25, 2025 | Natera Inc. | Grant or award | +142 | — | — |
| Jan 31, 2025 | Natera Inc. | Grant or award | +114 | — | — |
| Oct 25, 2024 | Natera Inc. | Grant or award | +153 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Derivative conversion | +1,638,236 | — | — |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +588,888 | $18.00 | $10,599,984 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +11,113 | $18.00 | $200,034 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +18,353 | $18.00 | $330,354 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +21,814 | $18.00 | $392,652 |
| Sep 27, 2024 | BioAge Labs Inc. | Open-market purchase | +26,497 | $18.00 | $476,946 |
Questions about James Healy
What boards is James Healy on?
James Healy sits on the boards of ArriVent BioPharma Inc., BioAge Labs Inc., Bolt Biotherapeutics Inc., Natera Inc., Rapport Therapeutics Inc. and Seaport Therapeutics Inc.
How long has James Healy served on boards?
Our records show at least 15 years of board service across 6 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.